Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2005-08-30
2005-08-30
Guzo, David (Department: 1636)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S455000, C435S468000, C435S006120, C435S008000, C435S019000, C435S021000
Reexamination Certificate
active
06936469
ABSTRACT:
Methods for delivering nucleic acid molecules into cells and methods for measuring nucleic acid delivery into cells and the expression of the nucleic acids are provided. The methods are designed for introduction of large nucleic acid molecules, including artificial chromosomes, into cells, and are practiced in vitro and in vivo.
REFERENCES:
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 4937190 (1990-06-01), Palmenberg et al.
patent: 5208066 (1993-05-01), Fujisaki et al.
patent: 5288625 (1994-02-01), Hadlaczky
patent: 5318515 (1994-06-01), Wilk
patent: 5334761 (1994-08-01), Gebeyehu et al.
patent: 5389069 (1995-02-01), Weaver
patent: 5459127 (1995-10-01), Felgner et al.
patent: 5501662 (1996-03-01), Hofmann
patent: 5507724 (1996-04-01), Hofmann et al.
patent: 5550289 (1996-08-01), Eppstein et al.
patent: 5676151 (1997-10-01), Yock
patent: 5695967 (1997-12-01), Van Bokkelen et al.
patent: 5712134 (1998-01-01), Hadlaczky
patent: 5721118 (1998-02-01), Scheffler
patent: 5736392 (1998-04-01), Hawley-Nelson et al.
patent: 5747338 (1998-05-01), Giese et al.
patent: 5830430 (1998-11-01), Unger et al.
patent: 5837283 (1998-11-01), McDonald et al.
patent: 5843884 (1998-12-01), Sims
patent: 5853694 (1998-12-01), Engberts et al.
patent: 5869294 (1999-02-01), Harrington et al.
patent: 5891691 (1999-04-01), Hadlaczky
patent: 5944710 (1999-08-01), Dev et al.
patent: 5962265 (1999-10-01), Norris et al.
patent: 5965396 (1999-10-01), Pan et al.
patent: 5976796 (1999-11-01), Szalay et al.
patent: 5976849 (1999-11-01), Hustad et al.
patent: 5985577 (1999-11-01), Bulinski
patent: 5993434 (1999-11-01), Dev et al.
patent: 6025155 (2000-02-01), Hadlaczky et al.
patent: 6027488 (2000-02-01), Hofmann et al.
patent: 6034228 (2000-03-01), Norris et al.
patent: 6037133 (2000-03-01), Li
patent: 6054312 (2000-04-01), Larocca et al.
patent: 6074667 (2000-06-01), Kinnunen et al.
patent: 6077697 (2000-06-01), Hadlaczky et al.
patent: 6184037 (2001-02-01), Rolland et al.
patent: 6743967 (2004-06-01), Hadlaczky et al.
patent: 2002/0160410 (2002-10-01), Hadlaczky et al.
patent: 2002/0160970 (2002-10-01), Hadlaczky et al.
patent: 2003/0033617 (2003-02-01), Hadlaczky et al.
patent: 2003/0059940 (2003-03-01), de Jong et al.
patent: 2003/0083293 (2003-05-01), Hadlaczky et al.
patent: 2003/0101480 (2003-05-01), Hadlaczky et al.
patent: 2003/0108914 (2003-06-01), Hadlaczky
patent: 2003/0113917 (2003-06-01), de Jong et al.
patent: 2003/0119104 (2003-06-01), Perkins et al.
patent: 2003/0186390 (2003-10-01), de Jong et al.
patent: 2003/0224522 (2003-12-01), de Jong et al.
patent: 2004/0214290 (2004-10-01), Perez et al.
patent: 0755924 (1997-01-01), None
patent: 0755924 (1999-06-01), None
patent: 9740183 (1997-10-01), None
patent: 9808964 (1998-03-01), None
patent: WO 99/13719 (1999-03-01), None
patent: 9921584 (1999-05-01), None
patent: 99/54445 (1999-10-01), None
patent: WO 0034436 (2000-06-01), None
Zelphati et al. Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA. Hum Gene Ther. Jan. 1, 1999;10(1):15-24.
Neves et al. Novel method for covalent fluorescent labeling of plasmid DNA that maintains structural integrity of the plasmid. Bioconjug Chem. Jan.-Feb. 2000;11(1):51-5.
Lee and Jaenisch, “A method for high efficiency YAC lipofection into murine embryonic stem cells”, Nucleic Acids Res. 24(24):5054-5055 (1996).
Monteith DP, Leung JD, Borowski AH, Co DO, Praznovszky T, Jirik FR, Hadlaczky G, Perez CF, “Pronuclear microinjection of purified artificial chromosomes for generation of transgenic mice: pick-and-inject technique,” Method Mol. Biol. 240:227-42 (2004).
Lindenbaum M, Perkins E, Csonka E, Fleming E, Garcia L, Greene A, Gung L, Hadlaczky G, Lee E, Leung J, MacDonald N, Maxwell A, Mills K, Monteith D, Perez CF, Shellard J, Stewart S, Stodola T, Vandenborre D, Vanderbyl S, Ledebur HC Jr., “A mammalian artificial chromosome engineering system (ACE System) applicable to biopharmaceutical protein production, transgenesis and gene-based cell therapy”,Nucleic Acids Res. Dec 07;32(21):e172 (2004).
Perez, CF, Vanderbly SL, Mills KA, Ledebur HC, “The ACE System: A versatile chromosome engineering technology with applications for gene-based cell therapy”, BioProcessing 2004; 3:61-68.
Rech et al., “Introduction of a yeast artificial chromosome vector intoSaccharomyces cereviseaecells by electroporation”, Nucleic Acids Res. 18(5):1313 (1990).
Tseng et al., “Mitosis enhances transgene expression of plasmid delivered by cationic liposomes”, Biochemica et Biophysica Acta 1445:53-64 (1999).
Vanderbyl S, MacDonald GN, Sidhu S, Gung L, Telenius A, Perez C, Perkins E, “Transfer and stable transgene expression of a mammalian artificial chromosome into bone marrow-derived human mesenchymal stem cells”, Stem Cells 22(3):324-33 (2004).
Albertsen et al., “Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents”,PNAS,87:4256-4260 (1990).
Alvaro-Gracia et al., “Cytokines in Chronic Inflammatory Arthritis. V. Mutual Antagonism between Interferon-Gamma and Tumor Necrosis Factor-Alpha on HLA-DR Expression, Proliferation, Collagenase Production, and Granulocyte Macrophage Colony-stimulating Factor Production by Rheumatoid Arthritis Synoviocytes”,J. Clin. Invest.,86:1790-1798 (1990).
Aupperle et al., “NF-κB Regulation by IκB Kinase in Primary Fibroblast-Like Synoviocytes”,J. Immunol.,163:427-433 (1999).
Brown et al., “Artificial chromosomes: ideal vectors?”,TIBTech,18:218-223 (2000).
Cavazzana-Calvo et al., “Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease”,Science,288:669-672 (2000).
Cocchia et al., “Recovery and potential utility of YACs as circular YACs/BACs”,Nucl. Acids Res.,28(17):e81 i-viii (2000).
Dausset et al., “The CEPH YAC Library”,Behring Inst. Mitt.,91:13-20 (1992).
de Jong et al., “Efficient in-vitro transfer of a 60-Mb mammalian artificial chromosome into murine and hamster cells using cationic lipids and dendrimers”,Chromosome Res.,9:475-485 (2001).
Foecking et al., “Powerful and versatile enhancer-promoter unit for mammalian expression vectors”,Gene,45:101-105 (1986).
Giraldo et al., “Size matters: use of YACs, BACs and PACs in transgenic animals”,Transgenic Res.,10:83-103 (2001).
Han et al., “Development of Biomaterials for Gene Therapy”,Mol. Therapy,2(4):302-317 (2000).
Hem et al., “Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guineapig, ferret and mink”,Laboratory Animals,32:364-368 (1998).
Jacobovits et al., “Germ-line transmission and expression of a human-derived yeast artificial chromosome”,Nature,362:255-258 (1993).
Kong et al., “Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand”,Nature,402:304-309 (1999).
Lange-Gustafson et al., “Purification and Properties of Int-h, a Variant Protein Involved in Site-specific Recombination of Bacteriophage λ”,J. Biol. Chem.,259(20):12724-12732 (1984).
Larin et al., “A method for linking yeast artificial chromosomes”,Nucl. Acid Res.,24(21):4192-4196 (1996).
Libert et al., “Construction of a Bovine Genomic Library of Large Yeast Artificial Chromosome Clones”,Genomics,18:270-276 (1993).
Lorbach et al., “Site-specific Recombination in Human Cells Catalyzed by Phage λ Integrase Mutants”,J. Mol. Biol.,296:1175-1181 (2000).
Lowry, R., “Two-Factor ANOVA with Repeated Measures on One Factor”, http://faculty.vassar.edu/lowry/anova2corr.html (2000).
Luo et al., “Synthetic DNA delivery systems”,Nature Biotechnol.,18:33-37 (2000).
Marschall et al., “Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine”,Gene Therapy,6:1634-1637 (1999).
Miller et
deJong Gary
Vanderbyl Sandra Louise
Chromos Molecular Systems Inc.
Fish & Richardson P.C.
Guzo David
Seidman Stephanie
Sullivan Daniel M.
LandOfFree
Methods for delivering nucleic acid molecules into cells and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for delivering nucleic acid molecules into cells and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for delivering nucleic acid molecules into cells and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3473043